Form 4 for MRK Merck & Co.
Accepted 2024-02-05 00:00:00 ET · period of report 2024-02-02 · accession 0001127602-24-003352 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-02-05 | 2024-02-02 | MRK | Oosthuizen Johannes Jacobus | Pres, U.S. Market | M - OptEx | $78.80 | +20.9K | 42.3K | +98% | +$1.65M |
| D | 2024-02-05 | 2024-02-02 | MRK | Oosthuizen Johannes Jacobus | Pres, U.S. Market | S - Sale+OE | $127.18 | -19.0K | 23.3K | -45% | -$2.41M |
| DM | 2024-02-05 | 2024-02-02 | MRK | Oosthuizen Johannes Jacobus | Pres, U.S. Market | M - OptEx | $0.00 | -20.9K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-02 | M | A | 6,773 | $75.36 | 28,122.35 | D | — | — | |
| 2 | Common | Common Stock | 2024-02-02 | S | D | 18,959 | $127.18 | 23,327.35 | D | — | — | (F1) Holdings include shares acquired in dividend reinvestment transactions. |
| 3 | Common | Common Stock | 2024-02-02 | M | A | 7,045 | $73.73 | 35,167.35 | D | — | — | |
| 4 | Common | Common Stock | 2024-02-02 | M | A | 7,119 | $87.10 | 42,286.35 | D | — | — | |
| 5 | Derivative | Stock Option (Right to Buy) | 2024-02-02 | M | D | 7,119 | $0.00 | 14,240 | D | $87.10 · 2023-05-03 to 2032-05-02 | 7,119 Common Stock | (F4) The option vests and becomes exercisable in three equal installments on 5/3/2023, 5/3/2024 and 5/3/2025. |
| 6 | Derivative | Stock Option (Right to Buy) | 2024-02-02 | M | D | 7,045 | $0.00 | 7,049 | D | $73.73 · 2022-05-04 to 2031-05-03 | 7,045 Common Stock | (F3) The option vests and becomes exercisable in three equal installments on 5/4/2022, 5/4/2023 and 5/4/2024. |
| 7 | Derivative | Stock Option (Right to Buy) | 2024-02-02 | M | D | 6,773 | $0.00 | 0 | D | $75.36 · 2021-05-01 to 2030-04-30 | 6,773 Common Stock | (F2) The option vested and became exercisable in three equal installments on 5/1/2021, 5/1/2022 and 5/1/2023. |